Actavis acquires PharmaPack International
Actavis buys a considerable amount of tablets from third-party manufacturers. "The lead times are sometimes between six and nine months and therefore much too long. With the acquisition of PharmaPack International we are able to reduce these lead times by more than 50 per cent," added Albrecht. One of the Dutch company's future roles will be the bulk packaging of pharmaceuticals produced in the Actavis facility in Alathur (India). Another advantage of this packaging centre will be a significant reduction in freight costs. In summary, PharmaPack International will increase the Group's cost competitiveness and have a very positive impact on Actavis' working capital.
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.